US FDA deems Sun Pharma's Halol plant not compliant with its manufacturing rules - Reuters
2 weeks ago • Google News
Sun Pharmaceutical Industries Limited (SUNPHARMA)
NSEINR 1648.61.75%
Price Chart
Key Statistics
Market Cap
INR 3.89T
P/E Ratio
37.40
Revenue (TTM)
INR 537.77B
Volume
1.83M
52W High
INR 1942.23
52W Low
INR 1547.96
Dividend Yield
0.00%
Beta
0.31
Technicals
50-Day MA
1637.936
200-Day MA
1705.95
52 Week High
1942.2259
52 Week Low
1547.9647
About SUNPHARMA
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, th.
Employees
43000
Headquarters
Mumbai, India
CEO
Mr. Dilip Shantilal Shanghvi
Latest News
Sun Pharma added to Citi's pan-Asia focus list with 35% upside - CNBC TV18
12 hours ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
39.89
Percentile: 86.78
Environmental Risk Score
3.07
Percentile: 4
Social Risk Score
25.2
Percentile: 4
Governance Risk Score
18.13
Percentile: 4
Controversy Level
ESG data provided by Sustainalytics, Inc.
SUNPHARMA
Category Average
3Significant Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg